Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0733 | 11.0792019347 | 0.6616 | 0.7349 | 0.63 | 341606 | 0.68347962 | CS |
4 | 0.0549 | 8.07352941176 | 0.68 | 0.76 | 0.62 | 605199 | 0.68444038 | CS |
12 | -0.9204 | -55.6032139189 | 1.6553 | 1.7382 | 0.6109 | 754223 | 0.87890972 | CS |
26 | -6.3751 | -89.6638537271 | 7.11 | 7.8 | 0.6109 | 836162 | 1.79030322 | CS |
52 | -5.1751 | -87.565143824 | 5.91 | 11.41 | 0.6109 | 510389 | 2.74222858 | CS |
156 | -6.8251 | -90.2791005291 | 7.56 | 11.41 | 0.6109 | 400295 | 4.08252942 | CS |
260 | -14.5551 | -95.1935905821 | 15.29 | 18.42 | 0.6109 | 279473 | 5.07933125 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관